April 17, 2017:
Shares of Dr Reddy's Laboratories rose as USFDA has completed Srikakulam plant audit with no observations.
The stock rose as much as 3.1 per cent. It was the top percentage gainer on NSE index posting biggest intra-day percentage gain in two weeks.
The US Food and Drug Administration (FDA) has completed the audit of co's Srikakulam plant in Andhra Pradesh, with no observations, according to an exchange filing on Friday.
Up to Thursday's close, the stock has fallen 13.7 per cent this year.
(This article was published on April 17, 2017)
Get more of your favourite news delivered to your inbox
Please enter your email. Thank You.
Newsletter has been successfully subscribed.